Skip to content
★ Sign in to follow
DH

David Holveck

CEO
Endo Pharmaceuticals Holdings Inc
Total declarations
17
Company
1
▲ Purchases (4 ops.)
€911k
▼ Sales (0 ops.)
—

Latest filing published 28 Feb 2013 for ENDO PHARMACEUTICALS HOLDINGS INC, €89k.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

David Holveck: trading record in brief

David Holveck appears in our data through filings on Endo Pharmaceuticals Holdings Inc shares, published by SEC (Form 4). The record holds 17 filings, for trades running from 26 February 2009 to 27 February 2013.

No open-market sale appears; the market trades are 4 purchases worth €911k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants and 3 option exercises.

The median purchase comes to €186k.

The newest entry dates from 28 February 2013: a share grant of €89k, in Endo Pharmaceuticals Holdings Inc. The latest purchase dates back some time: it was published 5,108 days ago, on 14 November 2012. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to David Holveck

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations